HOME >> BIOLOGY >> NEWS
FSU chemist Brschweiler awarded prestigious honor

TALLAHASSEE, Fla. -- A Florida State University professor of chemistry and biochemistry, Rafael P. Brschweiler, has been elevated to the rank of Fellow by the American Association for the Advancement of Science (AAAS).

In bestowing the honor, which was announced in the Nov. 24 issue of the journal Science, the AAAS recognized Brschweiler for fundamental contributions to methodology and applications of nuclear magnetic resonance spectroscopy in combination with computational approaches for the dynamic characterization of proteins in solutions.

In his research, Brschweiler, who also serves as associate director for biophysics at FSUs National High Magnetic Field Laboratory and is a member of the labs Science Council, works to increase scientists understanding of protein behavior, particularly how proteins interact with other molecules such as proteins, peptides and small ligands. Such an understanding is important for researchers as they attempt to develop new treatments for a variety of diseases.

Proteins are highly complex molecules that perform a wide range of biological functions in every organism, Bruschweiler said. Proper function requires the fine interplay between a proteins structure and its dynamics. In our work, we have shown how such protein behavior can be unraveled at the molecular level by the combined use of nuclear magnetic resonance experiments and sophisticated computational tools.

I have had the privilege to work with many talented coworkers and collaborators who have contributed in important ways to our research, he said, adding that I am delighted to be elected a Fellow of the AAAS.

In conducting his research at FSUs department of chemistry and biochemistry and at the magnet lab, Brschweiler has been an innovator in the use of nuclear magnetic resonance (NMR) technology for protein research. NMR is a research tool that utilizes high-powered magnets to measure the strengths, directions and temporary
'"/>

Contact: Rafael P. Brschweiler
bruschweiler@magnet.fsu.edu
850-644-1768
Florida State University
27-Nov-2006


Page: 1 2

Related biology news :

1. SNM initiatives supported by inclusions in NAS Report on competitiveness of US chemistry research
2. K-State biochemist contributes to article in Science magazine
3. Scientists propose the kind of chemistry that led to life
4. Turning the tables in chemistry
5. 2007 Image of the Year: Molecular imaging relates human brain chemistry to aggressive behavior
6. Better chemistry through living models
7. New chemistry approach promises less expensive drugs
8. Psychologist explains the neurochemistry behind romance
9. Yale chemists show that nature could have used different protein building blocks
10. UCSD scientists establish connection between life today and ancient changes in ocean chemistry
11. IUBMB selects Wiley to publish Biochemistry and Molecular Biology Education

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: FSU chemist Brschweiler awarded prestigious honor

(Date:7/23/2014)... Chrysomya megacephala is commonly found in dead bodies ... time of death, referred to as the post mortem ... C. megacephala from Tamil Nadu is provided for ... characterization through generation of DNA barcoding. This study, significant ... Biodiversity Data Journal . , Chrysomya megacephala ...
(Date:7/23/2014)... New Rochelle, NY -- The potential for clinical ... for transplant-based therapeutic strategies has previously been hindered ... the development of tumors. The ability to use ... for the treatment of heart disease, specifically acute ... Stem Cells and Development , a peer-reviewed ...
(Date:7/23/2014)... MINNETONKA, Minn. , July 23, 2014 /PRNewswire/ ... technology company specializing in clinical study management systems, ... West , a proven life sciences industry executive ... named Chief Operating Officer (COO).  Clareece will be ... and sales growth, operational efficiency and quality product/service ...
Breaking Biology News(10 mins):Dead body feeding larvae useful in forensic investigations 2MedNet Appoints Clareece West As Chief Operating Officer 2
(Date:7/23/2014)... July 23, 2014 ... of Trendlines Agtech , announced it has ... Israel,s leading agricultural thermoplastics applications companies. ... Valentis,s technology combines nanocrystalline cellulose (NCC), a biodegradable, ... additional nanoparticles to produce highly improved polymeric films. ...
(Date:7/23/2014)... regulated information -- UCB today announced an important advance ... topline results from the latest Phase 3 study ... evaluate the efficacy and safety of brivaracetam ... to placebo, as adjunctive treatment in adult focal ... despite treatment with one or two concomitant antiepileptic ...
(Date:7/23/2014)... 2014  Sofinnova Ventures, a Menlo Park ... of Sofinnova Venture Partners IX, L.P. at the hard ... initial fund target of $425 million. Sofinnova ... Consistent with recent funds, SVP IX will provide capital ... along with select investments in earlier stage opportunities. Investments ...
(Date:7/23/2014)... 2014 OncLive® is pleased to ... joined its Strategic Alliance Partnership program. , ... UNC Lineberger will have the opportunity to work ... its cutting-edge research initiatives, community-directed cancer prevention programs, ... work with OncLive to educate their peers by ...
Breaking Biology Technology:Valentis Nanotech Signs MOU to Integrate Technology in Thermoplastics Production 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7Sofinnova Raises $500 Million Biotech Venture Fund 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 3
Cached News: